2009•Zhongguo yaofangRequires access

Pharmacokinetics of Omeprazole Enteric-coated Tablets in Healthy Volunteers

Ming Yan

Open publisher page 0 citations

Abstract

OBJECTIVE: To study the pharmacokinetics of omeprazole in healthy volunteers.METHODS: 10 healthy volunteers(5 females and 5 males) were given a single oral dose(40 mg) of omeprazole tablets.Venous blood samples were collected at different time and subjected to sample treatment before the HPLC determination of the concentration of omeprazole in plasma samples.The parameters were treated using DAS 2.0 pharmacokinetics software and analyzed using SPSS 11.5 software.RESULTS: Themain pharmacokinetic parameters of omeprazole were as follows: Cmax(760.49±581.232)μg·L-1;tmax(2.7±0.823)h;t1/2(1.601±1.282)h;AUC0~12(1 437.61±798.045) μg·h·L-1;AUC0~∞(1 470.09±769.475)μg·h·L-1,which were in line with those reported in literature and of no statistical significance between different sex.CONCLUSION: The method adopted in our study can be used for the pharmacokinetic study of omeprazole.

About this research paper

What this paper is about

OBJECTIVE: To study the pharmacokinetics of omeprazole in healthy volunteers.METHODS: 10 healthy volunteers(5 females and 5 males) were given a single oral dose(40 mg) of omeprazole tablets.Venous blood samples were collected at different time and subjected to sample treatment before the HPLC determination of the concentration of omeprazole in plasma samples.The parameters were treated using DAS 2.0 pharmacokinetics software and analyzed using SPSS 11.5 software.RESULTS: Themain pharmacokinetic parameters of omeprazole were as follows: Cmax(760.49±581.232)μg·L-1;tmax(2.7±0.823)h;t1/2(1.601±1.282)h;AUC0~12(1 437.61±798.045) μg·h·L-1;AUC0~∞(1 470.09±769.475)μg·h·L-1,which were in line with those reported in literature and of no statistical significance between different sex.CONCLUSION: The method adopted in our study can be used for the pharmacokinetic study of omeprazole.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To study the pharmacokinetics of omeprazole in healthy volunteers.METHODS: 10 healthy volunteers(5 females and 5 males) were given a single oral dose(40 mg) of omeprazole tablets.Venous blood samples were collected at different time and subjected to sample treatment before the HPLC determination of the concentration of omeprazole in plasma samples.The parameters were treated using DAS 2.0 pharmacokinetics software and analyzed using SPSS 11.5 software.RESULTS: Themain pharmacokinetic parameters of omeprazole were as follows: Cmax(760.49±581.232)μg·L-1;tmax(2.7±0.823)h;t1/2(1.601±1.282)h;AUC0~12(1 437.61±798.045) μg·h·L-1;AUC0~∞(1 470.09±769.475)μg·h·L-1,which were in line with those reported in literature and of no statistical significance between different sex.CONCLUSION: The method adopted in our study can be used for the pharmacokinetic study of omeprazole.

Key concepts: Omeprazole, Pharmacokinetics, Cmax, Medicine, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics of Omeprazole Enteric-coated Tablets in Healthy Volunteers — Research Paper | ScholarLens